Biotechnology News

October 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, announced today a recent...

October 11, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Today on World Sight Day, 25 years after Merck (known as MSD outside the United States and Canada) started the MECTIZAN® Donation Program (MDP), the company celebrates with partners important progress in...

October 11, 2012

ST. PAUL, Minn. & LAS VEGAS--(BUSINESS WIRE)--Data presented today from Cardiovascular Systems’ CONFIRM study series demonstrate that CSI’s minimally invasive orbital atherectomy system is an effective treatment for peripheral arterial...

October 11, 2012

LOS ANGELES--(BUSINESS WIRE)--Genesis Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing targeted cellular immunotherapies for the treatment of cancer, today announced receipt of meeting minutes from the U.S. Food and Drug...

October 11, 2012

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Hospital CEOs say that a Medicare ruling making surgical site infections after cardiac implantable electronic device procedures non-reimbursable has significant financial and quality rating impacts.

October 11, 2012

SAN DIEGO & MINNEAPOLIS--(BUSINESS WIRE)--Cytori has treated the first patient at Minnesota Heart Institute Foundation in their U.S. ATHENA trial to study adipose-derived stem & regenerative cells in the treatment of refractory heart...

October 11, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics: (STO:PREC) Leading developer of solutions that trace key healthcare processes chooses Precise Match-on-Card™ to trace patient ID and blood testing transmissions, eliminating human ‘...

October 11, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals Initial Public Offering

October 11, 2012

FREDERICK, Md.--(BUSINESS WIRE)--Akonni Biosystems to Present Results of Development on a TruTip Automated Solution for Extracting Cell-free DNA from Maternal Plasma at
American Society of Human Genetics (ASHG) conference

October 11, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Nobel Prize Could Bring Big Investments in Stem Cell Research

October 11, 2012

CARY, N.C.--(BUSINESS WIRE)--The CEO Roundtable on Cancer’s Life Sciences Consortium has initiated Project Data Sphere, a collaborative data platform making clinical trials data available to researchers to speed cancer research.

October 11, 2012

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)--Today, Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that results from 11 company-sponsored TYSABRI presentations, including 10 posters and one platform, will be available...

October 11, 2012

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)--Today, Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that results from 11 company-sponsored TYSABRI presentations, including 10 posters and one platform, will be available...

October 11, 2012

CHICAGO & JENA, Germany--(BUSINESS WIRE)--Carl Zeiss advances surgical visualization with new 3D HD video system for the OPMI PENTERO microscope

October 10, 2012

BOCA RATON, Fla.--(BUSINESS WIRE)--Leading researchers from academia, government, private institutions, pharmaceutical and biotechnology companies, contract research companies and other stakeholders will gather November 15-18 at the CNS Summit...

October 10, 2012

LAS VEGAS--(BUSINESS WIRE)--Covidien's DEFINITIVE LE Study Confirms Effectiveness of Directional Atherectomy with SilverHawk™ and TurboHawk™ Devices as a Frontline Therapy when Treating PAD

October 10, 2012

BROOMFIELD, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, today announced that the paper "...

October 10, 2012

BEND, Ore.--(BUSINESS WIRE)--BiomarkerBase, the Clinical Biomarker Database, launches today to provide essential information about every molecular biomarker in active clinical use as a useful resource for biomarker stakeholders.

October 10, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Wednesday, October 24, 2012 at 8:30 a.m. Eastern Time (ET), 1:30 p.m. British Summer Time (BST) with the investment community to...

October 10, 2012

MURRAY HILL, N.J.--(BUSINESS WIRE)--The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 20 cents per share on Bard's common stock. The current indicated annual dividend rate is 80 cents per share....

October 10, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that its third quarter 2012 conference call and live webcast with financial analysts on Tuesday October 30, 2012 will now be held at 12:00 p.m. Eastern Time...

October 10, 2012

LONDON--(BUSINESS WIRE)--The discussion of the European Unitary Patent and the new Patent Box dominates the London Patent Summit, held on 8-9 October 2012 at the London Stock Exchange.

October 10, 2012

SAN ANTONIO--(BUSINESS WIRE)--Xenex has been awarded a U.S. General Services Administration (GSA) contract, making it even easier for federal agencies (including VA hospital systems) to purchase Xenex’s room disinfection systems.

October 10, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals Posts Lymphoseek® NDA Update to Company Website

October 10, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science Inc (NASD OTC: CBIS) and the World AIDS Institute announced today the appointment of Robert Melamede, PhD, Professor of Biology at the University of Colorado, Colorado Springs and CEO of...

October 10, 2012

ALEXANDRIA, Va.--(BUSINESS WIRE)--MPR establishes a new office in Chelmsford, MA to strategically meet the needs of our clients in the New England Region with a particular focus on the Life Sciences Industry.

October 10, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Data at Upcoming Scientific Meetings in October

October 10, 2012

MIAMI--(BUSINESS WIRE)--BioFlorida’s 15th Annual Conference highlights the growth and advancement of the bioscience industry. More than 500 attendees engaged with state & global leaders, including former Governor Jeb Bush.

October 10, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Bob Lefkowitz, a scientific founder of Trevena, Inc. wins the 2012 Nobel Prize for Chemistry.

October 10, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Researchers to Present Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS and STEC-HUS at ASN Annual Meeting

October 10, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--Advantest Corporation announced the opening of an office in Princeton, New Jersey, establishing a presence for the company in the heart of the pharma industry’s most research-intensive corridor.

October 10, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--New England Compounding Center (NECC), today announced that it has established a Recall Operations Center to process and manage the removal of all NECC products from circulation.

October 10, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--480 Biomedical announced today that the first twenty-five patients enrolled in its STANCE trial have been successfully implanted with the company’s fully self-expanding, bioresorbable scaffold.

October 10, 2012

LINCOLN, Neb.--(BUSINESS WIRE)--LI-COR announces the addition of new distributors in South Korea, Egypt, and Saudi Arabia to further expand the availability of environmental research tools.

October 10, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation announces the introduction of a novel ADCC Reporter Bioassay for Biologics.

October 10, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for air quality testing and certification services

October 10, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Better than nine out of 10 high-output pharmaceutical medical publications teams begin the year with dedicated budgets in place, according to a recent survey by Cutting Edge Information.

October 10, 2012

SAN DIEGO--(BUSINESS WIRE)--Scripps Center for Executive Health to Provide Patients with Pathway Genomics’ Genetic Tests

October 10, 2012

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals announced that the FDA designated radezolid as a Qualified Infectious Disease Product (QIDP) for oral and intravenous use for the indications of ABSSSI and CABP.

October 10, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research helps clients identify and strategically address early and ongoing device-related regulatory and clinical issues.

October 10, 2012

CINCINNATI--(BUSINESS WIRE)--Lynn Gold, vice president of chemistry, manufacturing and control at Camargo Pharmaceutical Services, will discuss development pathways for products being developed with new delivery technology

October 10, 2012

SOMERSET, N.J.--(BUSINESS WIRE)--Following a successful research collaboration, Catalent Pharma Solutions announces that it has taken an exclusive license to innovative taste-masking technology developed by the New Jersey Institute of Technology...

October 10, 2012

NAARDEN, The Netherlands--(BUSINESS WIRE)--BAC BV, the leading provider of antibody-based affinity purification technology, announced today that a successful long-term collaboration with GE Healthcare, the healthcare business of GE (NYSE: GE), to...

October 10, 2012

NEW YORK--(BUSINESS WIRE)--In 2050, the number of people aged 60 years and older worldwide will increase from 605 million to nearly 2 billion.2 While it’s good news that people are living longer, the number of older adults who will be affected by...

October 10, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced safety data from more than 62,400 people with multiple sclerosis (MS) taking AMPYRA (dalfampridine) Extended Release Tablets, 10 mg during the first two...

October 10, 2012

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte® Medical Systems today announced the appointment of Jack Darby to the position of President and Chief Executive Officer. Mark Pomeranz will continue to play a key leadership role at Svelte, serving as...